Vetter Pharma

OverviewSuggest Edit

Vetter Pharma is a company engaged in the production of aseptically prefilled syringe systems, cartridges, and vials. It operates as a contract development and manufacturing organization (CDMO) supporting its customers from the initial phases of clinical development and regulatory approval process through product launch, commercial manufacturing, and life cycle management. The company specializes in the development, clinical trial manufacturing, commercial manufacturing, lyophilization, labeling, and packaging technologies.

TypePrivate
Founded1950
HQRavensburg, DE
Websitevetter-pharma.com
Employee Ratings3.8

Latest Updates

Employees (est.) (Mar 2021)5,500(+10%)
Revenue (FY, 2018)€594.9 M(+6%)
Cybersecurity ratingCMore

Key People/Management at Vetter Pharma

Peter Soelkner

Peter Soelkner

Managing Director
Thomas Otto

Thomas Otto

Managing Director
Show more

Vetter Pharma Office Locations

Vetter Pharma has offices in Ravensburg, Langenargen, Des Plaines, Skokie and in 4 other locations
Ravensburg, DE (HQ)
Schützenstraße 87
Langenargen, DE
Eisenbahnstraße 2-4
Ravensburg, DE
Eywiesenstraße 5
Ravensburg, DE
Helmut-Vetter-Straße 10
Ravensburg, DE
Im Wiesental 7
Ravensburg, DE
Im Wiesental 7
Show all (13)

Vetter Pharma Financials and Metrics

Summary Metrics

Founding Date

1950
Show all financial metrics

Vetter Pharma Revenue

Vetter Pharma's revenue was reported to be €594.95 m in FY, 2018 which is a 5.9% increase from the previous period.
EUR

Revenue (FY, 2018)

594.9m

Revenue growth (FY, 2017 - FY, 2018), %

5.9%

Cash (31-Dec-2018)

3.9m
EURFY, 2016FY, 2017FY, 2018

Revenue

503.2m562.1m594.9m

Revenue growth, %

12%6%

General and administrative expense

228.5m253.2m265.6m

Operating expense total

228.5m253.2m265.6m
EURFY, 2016FY, 2017FY, 2018

Cash

9.0m1.7m3.9m

Accounts Receivable

90.8m107.4m107.8m

Prepaid Expenses

1.8m2.4m2.7m

Inventories

85.1m81.6m91.1m
EURFY, 2016

Revenue/Employee

134.9k

Debt/Equity

0.7 x

Debt/Assets

0.3 x

Financial Leverage

2.3 x
Show all financial metrics

Vetter Pharma Operating Metrics

FY, 2016FY, 2017FY, 2018

New Drugs Approved (EU)

2845

New Drugs Approved (Germany)

3136

New Drugs Approved (USA)

224659
Show all operating metrics

Vetter Pharma Acquisitions / Subsidiaries

Company NameDateDeal Size
Arzneimittel GmbH Apotheker Vetter & Co. KG
Vetter Commercial Manufacturing USA
Vetter Development Services USA, Inc
Vetter Pharma International GmbH
Vetter Pharma International Japan KK
Vetter Pharma International USA Inc

Vetter Pharma Cybersecurity Score

Cybersecurity ratingPremium dataset

C

79/100

SecurityScorecard logo

Vetter Pharma Online and Social Media Presence

Embed Graph

Vetter Pharma News and Updates

Vetter establishes office in China to better serve the needs of its growing customer base worldwide

Vetter, one of the global leaders in prefilled drug-delivery systems, today announced the opening of a new business entity in Shanghai, China. The new office, now its fourth in the Asia Pacific (APAC) region, will help increase the visibility of Vetter’s presence in China and underlines its importan…

Vetter continues its long-term investment strategy to sustain future growth

Vetter, a globally leading contract development and manufacturing organization (CDMO), has moved into its new headquarters in Ravensburg, Germany. The opening of the new building, known as Ravensburg Vetter Kammerbruehl, represents a clear signal from the family-owned company: stability and progress…

Teaming up to tackle drug development complexity

Vetter and Rentschler Biopharma are collaboratively developing a best-in-breed approach that reduces time-to-market. With global demand surging, biopharma companies are under significant pressure to accelerate new products to the clinic and market. At the same time, both the cost and complexity of d…

Increasing regulatory requirements demand innovative production methods

Ute Schleyer spoke with Outsourcing-Pharma about the factors driving demand for aseptic solutions, including V-CRT®. Demand for specialized treatments and therapies continues to surge around the world. At the same time, global health authorities are placing increasingly stringent demands on the asep…

Vetter opens new Training Center

On September 14, the Vetter Training Center site opened its doors – with a small celebration and a good atmosphere. The building, which has been specially converted for trainees and students, houses various workshops where they build their technical skills. They will also learn about innovative meth…

Vetter achieves carbon dioxide-neutral levels

Environmentally focused movements such as Fridays for Future are dedicated to increasing public awareness of climate protection. Vetter is equally committed to protecting the environment and has been focused on the issue of climate change as part of its corporate agenda for many years. In 2020, we r…
Show more

Vetter Pharma Frequently Asked Questions

  • When was Vetter Pharma founded?

    Vetter Pharma was founded in 1950.

  • Who are Vetter Pharma key executives?

    Vetter Pharma's key executives are Peter Soelkner and Thomas Otto.

  • How many employees does Vetter Pharma have?

    Vetter Pharma has 5,500 employees.

  • What is Vetter Pharma revenue?

    Latest Vetter Pharma annual revenue is €594.9 m.

  • What is Vetter Pharma revenue per employee?

    Latest Vetter Pharma revenue per employee is €108.2 k.

  • Who are Vetter Pharma competitors?

    Competitors of Vetter Pharma include B. Braun Melsungen, B. Braun and KBI Biopharma.

  • Where is Vetter Pharma headquarters?

    Vetter Pharma headquarters is located at Schützenstraße 87, Ravensburg.

  • Where are Vetter Pharma offices?

    Vetter Pharma has offices in Ravensburg, Langenargen, Des Plaines, Skokie and in 4 other locations.

  • How many offices does Vetter Pharma have?

    Vetter Pharma has 13 offices.